Advancing New Technologies for Brain Stimulation

Optoceutics aims to develop preventative solutions to neurodegenerative diseases by providing cutting edge technology that interact directly with disease causing modalities such as inflammation in the brain, amyloid load, and tau aggregation while enabling personalized care and

Read more Pre-order here
OptoLight

Investigational use

Optoceutics is currently planning clinical trials on the potential effect of masked 40 Hz light on Alzheimer’s Disease patients.

All devices used in trials are considerd investigational devices and limited to investigational use only.

Sign up for our newsletter to stay up to date on the latest information

Join mailing list

SELECTED PARTNERS

LATEST NEWS

Read more about the team behind the project.

MEET THE TEAM